Growth Equity Opportunities V LLC 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-22 4:06 pm Sale | 2022-07-11 | 13D | CTI BioPharma Corp. CTIC | Growth Equity Opportunities V LLC | 0 0.000% | -9,613,101 (Position Closed) | Filing |
| 2022-06-17 5:10 pm Purchase | 2022-06-07 | 13D | CTI BioPharma Corp. CTIC | Growth Equity Opportunities V LLC | 9,613,101 8.800% | 2,228,285 (+30.17%) | Filing |
| 2020-03-12 08:03 am Purchase | 2020-03-02 | 13D | CTI BioPharma Corp. CTIC | Growth Equity Opportunities V LLC | 7,384,816 9.990% | 3,634,816 (+96.93%) | Filing |
| 2020-02-13 10:46 am Unchanged | 2020-01-31 | 13D | CTI BioPharma Corp. CTIC | Growth Equity Opportunities V LLC | 3,750,000 6.500% | 0 (Unchanged) | Filing |